Royal Road Minerals Announces Appointment of Sarah Armstrong-Montoya to the Board of Directors, Establishment of Special Advisory Board, Issue of Stock Options

Toronto, Ontario--(Newsfile Corp. - May 13, 2025) - Royal Road Minerals Limited (TSXV: RYR) ("Royal Road" or the "Company") is pleased to announce the appointment of Sarah Armstrong-Montoya to the Board of Directors. Additionally, the Company has established a "Special Advisory Board, Safety, Security and Sustainability". Current Directors, Hugh Devlin and Guy Wallis, have proposed and agreed to step down from the Board of Directors in-order to occupy roles on the Special Advisory Board.

Sarah has a legal background and previously worked at Xstrata Copper, Linklaters (Hong Kong) and Corrs Chambers Westgarth (Australia). For the last 15 years Sarah has worked with the Ivanhoe group of companies where she has held various senior management positions, directing transactions throughout Asia-Pacific, North America and Latin America. In 2016, Sarah was appointed as Vice President, General Counsel of Cordoba Minerals Corp (TSXV: CDB) and in June 2018 she was appointed as President of subsidiary company, Minerales Cordoba S.A.S., managing all in-country operations in Colombia. Sarah was appointed as President and Chief Executive Officer of Cordoba Minerals Corp in April 2021.

Royal Road's commitment to safety, security and sustainability drives long-term value and reinforces its reputation as a responsible exploration and development company. The Company has managed and maintained the security and well-being of its employees in often complicated and testing operating environments and has been formally recognized and awarded for its innovative approach to sustainability. The appointment of Hugh and Guy to the newly established Special Advisory Board ensures rigor, independent audit and experienced direction of Royal Road's ongoing operations and sustainability initiatives.

The Company also announces that, effective May 19, 2025, it has granted an aggregate 1,250,000 stock options to purchase ordinary shares (the "Shares") in the capital of the Company, exercisable at a price of $0.15 per Share for a period of two (2) years to certain directors of the Company. The Shares issuable upon exercise of the options are subject to a four-month hold period from the original date of grant. As of the date hereof, the outstanding options, including the options granted effective May 19, 2025, represent approximately 6% of the issued and outstanding Shares of the Company.